THE ROGOSIN INSTITUTE INC
Programs
Program 1 [2020]
DIALYSIS FACILITIES: PROVIDES IN-CENTER AND HOME HEMODIALYSIS AND PERITONEAL DIALYSIS SERVICES FOR SOME 1,500 PATIENTS WITH KIDNEY FAILURE (END-STAGE KIDNEY DISEASE) THROUGH EIGHT CENTERS IN NEW YORK CITY (BROOKLYN, MANHATTAN AND QUEENS).GeographiesNot indicatedDatesJan 1, 2020 – Dec 31, 2020Source990No causes providedNo populations provided–$70.1MProgram 2 [2020]
IMMUNOGENETICS AND TRANSPLANTATION CENTER:A HISTOCOMPATIBILITY LABORATORY THAT PERFORMS TISSUE TYPING EVALUATIONS TO FACILITATE ORGAN TRANSPLANTATION.GeographiesNot indicatedDatesJan 1, 2020 – Dec 31, 2020Source990No causes providedNo populations provided–$8.2MProgram 3 [2020]
RESEARCH: A BROAD BASIC SCIENCE AND CLINICAL RESEARCH PROGRAM STUDIES ALL ASPECTS OF KIDNEY DISEASE AND RENAL REPLACEMENT THERAPY (DIALYSIS AND KIDNEY TRANSPLANTATION) AND DEVELOPS AND/OR TESTS NEW THERAPEUTIC MODALITIES, INCLUDING THOSE FOR KIDNEY DISEASE, DIABETES, LIPID DISORDERS AND CARDIOVASCULAR DISEASE, AS WELL AS CANCER.GeographiesNot indicatedDatesJan 1, 2020 – Dec 31, 2020Source990No causes providedNo populations provided–$8.5M
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)